✦ LIBER ✦

Immunologic studies in Burkitt's lymphoma

✍ Scribed by John L. Ziegler; Martin H. Cohen; Richard H. Morrow; Sebastian K. Kyalwazi; Paul P. Carbone

Publisher: John Wiley and Sons
Year: 1970
Tongue: English
Weight: 464 KB
Volume: 25
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197003)25:3<734::aid-cncr2820250335>3.0.co;2-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunologic observations in close relati

Immunologic observations in close relatives of two sisters with mammary Burkitt's lymphoma. Mammary Burkitt's lymphoma in sisters

✍ Lene O. Poulsen; Jeppe Hagstrup Christensen; Bente Sørensen; Peter Ebbesen; Gorm 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 380 KB 👁 2 views

Burkitt's lymphoma in Hertfordshire

✍ R. Stewart 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

WHAT IS BURKITT'S LYMPHOMA?

✍ WRIGHT, D. H. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB

Burkitt's lymphoma (BL) has been defined on the basis of its characteristic cytomorphology. Although histologically identical, endemic BL and sporadic BL are distinct clinico-anatomical entities. Their morphological identity probably relates to similar chromosomal translocations in both tumours, res

Burkitt's lymphoma outside Africa

📂 Article 📅 1967 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

Jaw involvement in American Burkitt's ly

Jaw involvement in American Burkitt's lymphoma

✍ E. Sariban; A. Donahue; I. T. Magrath 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 457 KB 👁 2 views

A total of 100 patients with American Burkitt's lymphoma (AMBL) (mean age, 15 years; M:F ratio 3:l; 3% black) have been treated at the National Cancer Institute since 1964. Eighteen of these had jaw involvement, 16 at presentation and 2 at relapse (mean age, 16 years; M:F ratio 1.6:l). None of these

Burkitt's lymphoma. A clinical study of

Burkitt's lymphoma. A clinical study of 110 patients

✍ F. K. Nkrumah; I. V. Perkins 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 467 KB 👁 2 views

O n e hundred and ten previously untreated patients with Burkitt's lymphoma were studied prospectively over a period ranging from over 1 year to 5 years. Of 103 patients who were treated with cyclophosphamide as a single agent, 79 (77%) achieved complete remission. Vincristine plus methotrexate o r